The TEG 5000 Thrombelastograph Hemostatis Analyzer System is utilized to help assess bleeding and thrombotic risks, and to monitor antithrombotic therapies. The diagnostic instrument provides comprehensive whole blood hemostatis testing, giving a full picture of a patient?s hemostasis. This enables more targeted treatment to be given. The PlateletMapping Assay can identify the possible response to antiplatelet therapy in relation to the hemostasis. The TEG 5000 system is considered to be the new standard of care relating to hemostasis management due to the graphical and numerical data output, variety of tests available, and remote data viewing. With these improved outcomes for patients, the system reduces the need for unnecessary blood component transfusions, and is also very cost-effective.